Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Lyrica
Pharma
Viatris' growth story hinges on M&A: analyst
As legacy Upjohn's business prospects in China and Japan remain unclear, M&A will be critical to Viatris' growth, one analyst says.
Angus Liu
Nov 18, 2020 11:46am
EU clears merger of Mylan and Pfizer's Upjohn with conditions
Apr 23, 2020 11:14am
Pfizer’s bulked-up Viatris may not reap rewards: analysts
Jan 29, 2020 12:04pm
ICER lambasts AbbVie, Roche for 'unsupported' price hikes
Oct 8, 2019 10:50am
Pfizer's Lyrica market share crumbles under generic onslaught
Aug 19, 2019 9:59am
With its generic spinoff cash, will Pfizer step up its buying game?
Jul 30, 2019 10:53am
